Lymphoblastic Lymphoma

Lymphoblastic Lymphoma is an aggressive cancer that can affect either type of lymphocyte. It is most commonly found in T-cells (almost 90% of cases), but some types arise from immature B-cells.

Though this cancer is rare and accounts for only 2% of Non-Hodgkin’s diagnoses per year, it is very common in children. In fact, up to 30% of all childhood lymphomas diagnosed per year will be lymphoblastic lymphoma.

In most cases, lymphoblastic lymphoma progresses to Stage IV prior to diagnosis. Tumors in this stage have spread to the bone marrow, spleen, and central nervous system. Symptoms include swollen lymph nodes, fatigue, weight loss, and night sweats.

Diagnosis and Staging of Lymphoblastic Lymphoma

To accurately diagnose and stage this disease, doctors may use blood work and bone marrow or lymph node biopsies. By examining the biopsied tissue under a microscope, doctors can identify the mutations that cause lymphoblastic lymphoma and make an accurate diagnosis. To determine the spread and stage of the disease, doctors may also use chest X-rays, CT scans, PET scans, or ultrasounds. Staging is as follows:

Stage I
Involvement of one group of lymph nodes on one side of the diaphragm.
Stage II
Involvement of two groups of lymph nodes on the same side of the diaphragm.
Stage III
Lymph involvement on both sides of the diaphragm. This stage may also be marked by involvement of the lungs or a mass in the chest.
Stage IV
Marked by spread into the central nervous system and/or bone marrow.

Treatment

The most common treatment is chemotherapy. The CHOP regimen has been used with great success, as has a newer regimen called hyper-CVAD (cytoxan, vincristine, adriamycin, and dexamethasone).

In some cases, radiation therapy will be used with chemotherapy, though it is never used as a sole treatment.

Radioimmunotherapy is also being researched as a treatment.

Cancer Patients have more options through clinical studies. Follow this link to learn more about clinical study opportunities near you.

Related Articles

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap